CI
Cytokinetics Incorporated
CYTK· Health Care· BiotechnologyS&P 400
Close · 23/10/2026
61.23
1D
-1.76%52-week range
54.3 – 88.31
Volume
9,85,600.00
Price history
CYTK
24/09/2026 to 23/10/2026
O 62.01 H 62.44 L 60.89
1W-1.16%
1M-6.75%
3M-24.05%
6M-6.26%
1Y+11.82%
3Y+78.51%
5Y+65.98%
MAX+100.36%
Fundamentals
as of 23/10/2026- Market cap
- $8.51B
- Shares out
- 139.02M
- P/E (forward)
- -13.91
- EPS (trailing)
- -6.43
- Dividend yield
- 0.00%
- Beta
- 0.41
- Profit margin
- -1321.12%
- P/B
- -48.98
SEC financial statements
56 quarterly and 27 annual periods through 30/06/2026.
Details
- Ticker
- CYTK
- Index
- SP400
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 23/10/2026.
Tracked by Congress
2 filers · 0 on watchlist · 4 buys · 1 sell · D: 3 · R: 2
- 29/09/2026Gilbert CisnerosBuyCytokinetics, Incorporated - Common Stock$1,001–$15,000
- 30/06/2026Gilbert CisnerosBuyCytokinetics, Incorporated - Common Stock$1,001–$15,000
- 09/10/2025Gilbert CisnerosBuyCytokinetics, Incorporated - Common Stock$1,001–$15,000
- 17/06/2025Lisa McClainSellCytokinetics, Incorporated - Common Stock$1,001–$15,000
- 11/06/2025Lisa McClainBuyCytokinetics, Incorporated - Common Stock$1,001–$15,000